Kenya’s 2026–2030 Health Products and Technologies Local Manufacturing Strategy targets local production of at least 50 per cent of the country’s essential health products.
During this period, manufacturers and importers will implement authentication and traceability for locally manufactured and imported HPTs through batch-level traceability using batch numbers declared to the PPB.
Phesgo, manufactured by Roche, contains a combination of Pertuzumab and Trastuzumab and is used in the treatment of specific types of breast cancer.
CS Duale demanded the swift removal of all substandard, falsified, poor-quality, counterfeit, and unregistered medicines from the Kenyan market.